AI Detection and Repurposed Drugs Signal New Era in Food Allergy Research at Food Allergy Fund Summit

The Food Allergy Fund (FAF) today convened scientists, investors, policymakers, and advocates at its annual Summit in New ...
Frontiers

AI-Driven Insights into Host-Pathogen Interactions and Antimicrobial Drug Discovery in a One Health Framework

The rapid emergence of antimicrobial resistance (AMR) and zoonotic pathogens underscores the urgent need for innovative, interdisciplinary strategies to ...
Technology Networks

Drug Repurposing To Tackle Multiple Sulfatase Deficiency

Drug repurposing could help find a treatment for multiple sulfatase deficiency, a rare genetic disease that currently has no ...
app.com

Solix and Symbiosis (SCEI & SMCW) Partner to Launch Center of Excellence for New Drug Discovery and Repurposing

PUNE, MAHARASHTRA, INDIA, March 17, 2026 /EINPresswire.com/ — Solix Technologies and Symbiosis Center for Entrepreneurship & Innovation in collaboration with ...
Hosted on MSN

AI identifies two existing drugs as candidates for Leigh syndrome

Researchers from Germany and Luxembourg have used AI and brain organoid models to identify two existing drugs, talarozole and sertaconazole, as potential treatments for Leigh syndrome. The approach ...

AI screening in brain organoids uncovers two drug candidates for Leigh syndrome

The need for medical treatments for rare diseases such as Leigh syndrome is high. However, low patient numbers make research ...
News-Medical.Net

Why AI is becoming a powerful tool in cancer drug discovery

This Perspective reviews how AI is moving drug discovery from long, costly experimental pipelines toward earlier clinical translation, with an AI-designed TNIK inhibitor trial serving as an important ...